References

10.1186/1471-2377-10-46

10.1186/1471-2377-10-46 · External reference

10.17650/2222-8721-2018-8-3-12-18

10.17650/2222-8721-2018-8-3-12-18 · External reference

10.1212/wnl.0000000000002796

10.1212/wnl.0000000000002796 · External reference

10.1016/j.neurobiolaging.2018.12.011

10.1016/j.neurobiolaging.2018.12.011 · External reference

10.1080/14737175.2019.1600404

10.1080/14737175.2019.1600404 · External reference

10.1038/s41572-019-0079-y

10.1038/s41572-019-0079-y · External reference

Lifetime course of myasthenia gravis

10.1002/mus.20950 · 2008 · External reference

10.12688/f1000research.15973.1

10.12688/f1000research.15973.1 · External reference

10.1007/978-981-13-3681-2_17

10.1007/978-981-13-3681-2_17 · External reference

Clinical features of patients with myasthenia gravis associated with autoimmune diseases

10.1111/j.1468-1331.2007.01978.x · 2007 · External reference

Clinical evaluation and management of myasthenia gravis

10.1002/mus.20030 · 2004 · External reference

Unresolved reference

External reference

10.1002/ana.20061

10.1002/ana.20061 · External reference

10.1055/s-2004-829594

10.1055/s-2004-829594 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Cerebral small vessel disease: from pathogenesis and clini cal characteristics to therapeutic challenges

10.1016/s1474-4422(10)70104-6 · 2010 · External reference

Unresolved reference

External reference

10.1212/wnl.0000000000002790

10.1212/wnl.0000000000002790 · External reference

Developing treatment guidelines for myasthenia gravis

10.1111/nyas.13537 · 2018 · External reference

10.1371/journal.pone.0032487

10.1371/journal.pone.0032487 · External reference

Clinical Characteristics of Pediatric Myasthenia: A Surveillance Study

10.1542/peds.2013-0814 · 2013 · External reference